CRPC
Clinical trials for CRPC explained in plain language.
Never miss a new study
Get alerted when new CRPC trials appear
Sign up with your email to follow new studies for CRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced prostate cancer: enhertu trial launches
Disease control Recruiting nowThis study tests the drug Enhertu in 60 men with a specific type of advanced prostate cancer (HER2-positive) that has stopped responding to standard hormone therapy and chemotherapy. The goal is to see if Enhertu can shrink tumors or slow the cancer's growth. Participants must ha…
Matched conditions: CRPC
Phase: PHASE2 • Sponsor: Washington D.C. Veterans Affairs Medical Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for tough cancers: experimental drug JAB-8263 enters human trials
Disease control Recruiting nowThis study tests a new drug called JAB-8263 in adults with advanced solid tumors (like lung or ovarian cancer) or blood cancers (like leukemia) that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 15…
Matched conditions: CRPC
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC